Monoclonal Antibodies to Treat Multiple Myeloma: A Dream Come True

by Mattia D’Agostino, Salvatore Innorcia, Mario Boccadoro, Sara Bringhen
Published 2020-11-01

The Role of Monoclonal Antibodies in the First-Line Treatment of Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma

by Francesca Bonello, Mariella Grasso, Mattia D’Agostino, Ivana Celeghini, Alessia Castellino, Mario Boccadoro, Sara Bringhen
Published 2021-12-01

Melflufen: A Peptide–Drug Conjugate for the Treatment of Multiple Myeloma

by María-Victoria Mateos, Joan Bladé, Sara Bringhen, Enrique M Ocio, Yvonne Efebera, Luděk Pour, Francesca Gay, Pieter Sonneveld, Joachim Gullbo, Paul G. Richardson
Published 2020-09-01

Cardiovascular Organ Damage and Blood Pressure Levels Predict Adverse Events in Multiple Myeloma Patients Undergoing Carfilzomib Therapy

by Giulia Bruno, Sara Bringhen, Ilaria Maffei, Andrea Iannaccone, Teresa Crea, Agnese Ravera, Anna Astarita, Fabrizio Vallelonga, Marco Salvini, Francesca Gay, Franco Veglio, Alberto Milan
Published 2019-05-01

Place in therapy of innovative drugs in multiple myeloma in 2021 and 2023 according to an expert panel Delphi consensus

by Mario Boccadoro, Patrizia Berto, Sara Bringhen, Elena Zamagni, Patrizia Tosi, Nicola Cascavilla, Nicola Giuliani, Donato Mannina, Renato Zambello, Francesca Patriarca, Vittorio Montefusco, Mariella Grasso, Francesco Di Raimondo, Massimo Offidani, Maria Teresa Petrucci, Pellegrino Musto
Published 2021-07-01

Effects of Carfilzomib Therapy on Left Ventricular Function in Multiple Myeloma Patients

by Giulia Mingrone, Anna Astarita, Lorenzo Airale, Ilaria Maffei, Marco Cesareo, Teresa Crea, Giulia Bruno, Dario Leone, Eleonora Avenatti, Cinzia Catarinella, Marco Salvini, Giusy Cetani, Francesca Gay, Sara Bringhen, Franco Veglio, Fabrizio Vallelonga, Alberto Milan
Published 2021-04-01

Multiple Myeloma Patients Undergoing Carfilzomib: Development and Validation of a Risk Score for Cardiovascular Adverse Events Prediction

by Anna Astarita, Giulia Mingrone, Lorenzo Airale, Fabrizio Vallelonga, Michele Covella, Cinzia Catarinella, Marco Cesareo, Giulia Bruno, Dario Leone, Carlo Giordana, Giusy Cetani, Marco Salvini, Francesca Gay, Sara Bringhen, Franco Rabbia, Franco Veglio, Alberto Milan
Published 2021-04-01

ISATUXIMAB PLUS POMALIDOMIDE AND DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA AND SOFT-TISSUE PLASMACYTOMAS: ICARIA-MM SUBGROUP ANALYSIS

by M.E.Z. Capra, M. Beksac, P.G. Richardson, A. Unal, P. Corradini, S. Delimpasi, Z. Gulbas, G. Mikala, A. Neylon, A. Symeonidis, S. Bringhen, P. Moreau, H.V. Velde, F. Campana, S.L. Guennec, I. Spicka
Published 2020-11-01

Octogenarian newly diagnosed multiple myeloma patients without geriatric impairments: the role of age >80 in the IMWG frailty score

by Mattia D’Agostino, Alessandra Larocca, Massimo Offidani, Anna Marina Liberati, Gianluca Gaidano, Maria Teresa Petrucci, Daniele Derudas, Andrea Capra, Renato Zambello, Nicola Cascavilla, Paolo de Fabritiis, Vanessa Innao, Francesca Bonello, Francesca Patriarca, Giulia Benevolo, Nicola Giuliani, Gabriele Aitoro, Tommasina Guglielmelli, Francesco Di Raimondo, Paolo Corradini, Pellegrino Musto, Roman Hájek, Pieter Sonneveld, Mario Boccadoro, Sara Bringhen
Published 2021-04-01

Prognostic or predictive value of circulating cytokines and angiogenic factors for initial treatment of multiple myeloma in the GIMEMA MM0305 randomized controlled trial

by Ilaria Saltarella, Fortunato Morabito, Nicola Giuliani, Carolina Terragna, Paola Omedè, Antonio Palumbo, Sara Bringhen, Lorenzo De Paoli, Enrica Martino, Alessandra Larocca, Massimo Offidani, Francesca Patriarca, Chiara Nozzoli, Tommasina Guglielmelli, Giulia Benevolo, Vincenzo Callea, Luca Baldini, Mariella Grasso, Giovanna Leonardi, Manuela Rizzo, Antonietta Pia Falcone, Daniela Gottardi, Vittorio Montefusco, Pellegrino Musto, Maria Teresa Petrucci, Franco Dammacco, Mario Boccadoro, Angelo Vacca, Roberto Ria
Published 2019-01-01